Bill > H3481

This bill aims to ensure the fair, transparent, and patient-focused use of health technology assessments (HTAs) by the Commonwealth. It sets several requirements for the Executive Office of Health and Human Services (EOHHS) when relying on HTAs to support supplemental rebate agreement negotiations for prescription drugs. Key provisions include: prohibiting the use of HTAs funded by certain entities, requiring disclosure of HTA funding sources and methodology, mandating advance notice and disclosure of non-public models to drug manufacturers, and requiring patient, caregiver, and external expert input in the HTA process. The bill also prohibits the EOHHS from denying Medicaid recipients access to any prescription drug covered under a Medicaid drug rebate agreement based on an HTA.

Health and Social Services

https://malegislature.gov/Bills/191/H3481